Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Institució Catalana de Recerca i Estudis Avançats · Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
318
total citations
- FWCI
- 98.74
- Percentile
- 100%
- References
- 166
Citations per year
Authors
9- JMJosep M. LlovetCorresponding
Institució Catalana de Recerca i Estudis Avançats, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Icahn School of Medicine at Mount Sinai
- RPRoser Pinyol
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona
- MYMark Yarchoan
Bloomberg (United States), Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
- AGAmit G. Singal
The University of Texas Southwestern Medical Center
- TUThomas U. Marron
Icahn School of Medicine at Mount Sinai
Topics & keywords
Topics
Keywords
- Medicine
- Oncology
- Hepatocellular carcinoma
- Internal medicine
- Clinical trial
- Cancer
- Liver transplantation
- Adjuvant
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- CRCancer Research UKAwards: A26813, C9380/A26813
- ECEuropean CommissionAward: 101136622
- FCFundación Científica Asociación Española Contra el CáncerAwards: C9380/A26813, PRYGN223117LLOV
- GDGeneralitat de Catalunya
- MDMinisterio de Ciencia e InnovaciónAward: PID2022
- AIAssociazione Italiana per la Ricerca sul CancroAwards: A26813, C9380/A26813
- NINational Institutes of HealthAwards: RO1DK128289, RO1DK56621
- HEHORIZON EUROPE Framework Programme
- ADAgència de Gestió d'Ajuts Universitaris i de Recerca